Gary A. Lyons, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 15,000 shares at $114.41 ($1.7M) on 2018-11-02, disclosed to the SEC on 2018-11-05.
Open-market sale of $1.7M NBIX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2025-12-04 | $2.3M | — | Filing → |
| TVTX | SELL | 2024-10-04 | $1.2M | — | Filing → |
| NBIX | SELL | 2024-08-15 | $3.5M | — | Filing → |